Analysis of Human Movement With Assistive Devices

Sponsor
Orthocare Innovations, LLC (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05729061
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
100
1
2
12
8.3

Study Details

Study Description

Brief Summary

The purpose of this research is to evaluate how people move about in different settings with different assistive devices or components, and to understand how people interact with different assistive technologies. Individuals that have limb weakness, limb paralysis, limb loss, and movement disorders are often provided assistive devices such as prostheses and orthoses to assist with mobility or use assistive technologies for purposes such as to regain muscle strength or retrain movements. It is important to understand the impact of these different assistive technologies on human movement for technology improvement and in preparation for commercialization.

Because this research focuses on evaluating how different people move about in different settings with different assistive devices/components, there are different activities that may take place. These activities have been classified as (1) Movement Analysis in the Laboratory, (2) Movement Analysis Outside the Laboratory, (3) Usability Testing, and (4) Focus Groups. Each participant may or may not complete the same activities as the other participants. Each participant may or may not complete all of the activities. Participants may complete the activities more than once.

Condition or Disease Intervention/Treatment Phase
  • Device: Assist-Knee
  • Device: Prosthetic Knee
  • Device: Prosthetic Ankle
  • Device: Prosthetic Foot
  • Device: Ankle-Foot Orthosis
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Analysis of Human Movement With Assistive Devices
Actual Study Start Date :
Nov 28, 2022
Anticipated Primary Completion Date :
Nov 28, 2023
Anticipated Study Completion Date :
Nov 28, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Participant with normal assistive device

Normal assistive device refers to the habitual assistive device that may be prescribed by a provider of care or no assistive device if the individual does not normally use.

Other: Participant with intervention

Intervention refers to investigational assistive devices or commercially available assistive devices that individuals may use during this study.

Device: Assist-Knee
Investigational prosthetic knee-ankle device

Device: Prosthetic Knee
Commercially available prosthetic knee devices

Device: Prosthetic Ankle
Commercially available prosthetic ankle devices

Device: Prosthetic Foot
Commercially available prosthetic foot devices

Device: Ankle-Foot Orthosis
Commercially available ankle-foot orthosis devices

Outcome Measures

Primary Outcome Measures

  1. Walking Speed with no intervention [Collection at baseline]

    Walking speed determined over 8 meters of walking

  2. Walking Speed with intervention [Collection immediately after acclimation with intervention]

    Walking speed calculated over 8 meters of walking

Secondary Outcome Measures

  1. Time to Complete Sit-to-Stand with no intervention [Collection at baseline]

    The amount of time, measured in seconds, needed by the subject to complete the sit-to-stand transition. At least three trials of the sit-to-stand maneuver are collected for each participant using a motion analysis system. Average and standard deviation of the time to complete the sit-to-stand transition are calculated for each participant. The start of the transition will be determined by participant initiation; the end of the transition will be determined by the participant reaching full knee extension.

  2. Time to Complete Sit-to-Stand with intervention [Collection immediately after acclimation with intervention]

    The amount of time, measured in seconds, needed by the subject to complete the sit-to-stand transition. At least three trials of the sit-to-stand maneuver are collected for each participant using a motion analysis system. Average and standard deviation of the time to complete the sit-to-stand transition are calculated for each participant. The start of the transition will be determined by participant initiation; the end of the transition will be determined by the participant reaching full knee extension.

  3. Timed Up and Go (TUG) Test [Collection at baseline]

    The Timed Up and Go (TUG) test is a validated timed functional test that involves standing up from a chair, walking forward for 3 meters, turning around, walking back to the chair for 3 meter, and sitting down. Each participant will complete the TUG test for three trials. Time is measured using a stopwatch. Average and standard deviation of the time to complete the TUG test are calculated for each participant.

  4. Timed Up and Go (TUG) Test with intervention [Collected immediately after acclimation with intervention]

    The Timed Up and Go (TUG) test is a validated timed functional test that involves standing up from a chair, walking forward for 3 meters, turning around, walking back to the chair for 3 meter, and sitting down. Each participant will complete the TUG test for three trials. Time is measured using a stopwatch. Average and standard deviation of the time to complete the TUG test are calculated for each participant.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria for Nondisabled Participants:
  • Age 18 - 90 years

  • Has bilateral normal range of motion

  • Able to perform a variety of movement activities

  • Able to communicate and write individual perceptions in English

  • Able to provide written informed consent

  • Participants that will use a treadmill during data collection must also be able to walk independently and safely on a treadmill

Exclusion Criteria for Nondisabled Participants:
  • Health issues (e.g., confounding injury, musculoskeletal, or cognitive) or other issues (e.g., transportation or schedule issues) that limit effective participation and/or may not represent a nondisabled condition

  • Pregnancy

  • Not able to read and understand English

Inclusion Criteria for Participants with a Disability:
  • Age 18 - 90 years

  • Has a condition or diagnosis that results in limb weakness, limb paralysis, limb loss, or movement disorders

  • Medically stable

  • Has stable balance

  • Able to perform a variety of movement activities

  • Able to communicate and write individual perceptions in English

  • Able to provide written informed consent

  • Participants that will use a treadmill during data collection must also be able to walk independently and safely on a treadmill

  • Able to safely complete the movements being tested and/or safely use the assistive devices being tested

Exclusion Criteria for Participants with a Disability:
  • Health issues (e.g., confounding injury, musculoskeletal, or cognitive) or other issues (e.g., transportation or schedule issues) that limit effective participation and/or may result in mixed effects of multiple sources of disability

  • Pregnancy

  • Not able to read and understand English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orthocare Innovations, LLC Edmonds Washington United States 98020

Sponsors and Collaborators

  • Orthocare Innovations, LLC
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Sarah Chang, PhD, Orthocare Innovations, LLC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Orthocare Innovations, LLC
ClinicalTrials.gov Identifier:
NCT05729061
Other Study ID Numbers:
  • AD-001
  • R44HD097826
First Posted:
Feb 15, 2023
Last Update Posted:
Feb 21, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2023